BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26921195)

  • 1. Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease.
    Ramraj SK; Aravindan S; Somasundaram DB; Herman TS; Natarajan M; Aravindan N
    Oncotarget; 2016 Apr; 7(14):18605-19. PubMed ID: 26921195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells.
    Khan FH; Pandian V; Ramraj S; Aravindan S; Herman TS; Aravindan N
    BMC Genomics; 2015 Jul; 16(1):501. PubMed ID: 26148557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma.
    Gholamin S; Mirzaei H; Razavi SM; Hassanian SM; Saadatpour L; Masoudifar A; ShahidSales S; Avan A
    J Cell Physiol; 2018 Feb; 233(2):866-879. PubMed ID: 28145567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14.
    Xiang X; Mei H; Zhao X; Pu J; Li D; Qu H; Jiao W; Zhao J; Huang K; Zheng L; Tong Q
    Oncotarget; 2015 Sep; 6(26):22452-66. PubMed ID: 26084291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
    Yang XH; Tang F; Shin J; Cunningham JM
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients.
    Zeka F; Decock A; Van Goethem A; Vanderheyden K; Demuynck F; Lammens T; Helsmoortel HH; Vermeulen J; Noguera R; Berbegall AP; Combaret V; Schleiermacher G; Laureys G; Schramm A; Schulte JH; Rahmann S; Bienertová-Vašků J; Mazánek P; Jeison M; Ash S; Hogarty MD; Moreno-Smith M; Barbieri E; Shohet J; Berthold F; Van Maerken T; Speleman F; Fischer M; De Preter K; Mestdagh P; Vandesompele J
    JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of miRNAs that are associated with tumor metastasis in neuroblastoma.
    Guo J; Dong Q; Fang Z; Chen X; Lu H; Wang K; Yin Y; Cai X; Zhao N; Chen J; Zen K; Zhang J; Zhang CY
    Cancer Biol Ther; 2010 Mar; 9(6):446-52. PubMed ID: 20147780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of microRNAs in neuroblastoma.
    Mei H; Lin ZY; Tong QS
    World J Pediatr; 2014 Feb; 10(1):10-6. PubMed ID: 24464658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma.
    Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY
    Genet Mol Res; 2015 Dec; 14(4):16297-307. PubMed ID: 26662423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma.
    Mohammadi M; Goodarzi M; Jaafari MR; Mirzaei HR; Mirzaei H
    Cancer Gene Ther; 2016 Nov; 23(11):371-372. PubMed ID: 27740613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in Neuroblastoma: Biomarkers with Therapeutic Potential.
    Galardi A; Colletti M; Businaro P; Quintarelli C; Locatelli F; Di Giannatale A
    Curr Med Chem; 2018 Feb; 25(5):584-600. PubMed ID: 28971761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.
    Sandoval JA; Turner KE; Hoelz DJ; Rescorla FJ; Hickey RJ; Malkas LH
    J Surg Res; 2007 Oct; 142(2):268-74. PubMed ID: 17727886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7.
    Li Y; Wang H; Li J; Yue W
    Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):48-55. PubMed ID: 24345480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?
    Margue C; Reinsbach S; Philippidou D; Beaume N; Walters C; Schneider JG; Nashan D; Behrmann I; Kreis S
    Oncotarget; 2015 May; 6(14):12110-27. PubMed ID: 25883223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients.
    Stigliani S; Scaruffi P; Lagazio C; Persico L; Carlini B; Varesio L; Morandi F; Morini M; Gigliotti AR; Esposito MR; Viscardi E; Cecinati V; Conte M; Corrias MV
    Oncotarget; 2015 May; 6(15):13295-308. PubMed ID: 25980492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-expression-based analysis of local and metastatic neuroblastoma variants reveals a set of genes associated with tumor progression in neuroblastoma patients.
    Nevo I; Oberthuer A; Botzer E; Sagi-Assif O; Maman S; Pasmanik-Chor M; Kariv N; Fischer M; Yron I; Witz IP
    Int J Cancer; 2010 Apr; 126(7):1570-81. PubMed ID: 19739072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miRNAs are correlated with tumor progression in prostate cancer.
    Brase JC; Johannes M; Schlomm T; Fälth M; Haese A; Steuber T; Beissbarth T; Kuner R; Sültmann H
    Int J Cancer; 2011 Feb; 128(3):608-16. PubMed ID: 20473869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
    Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease.
    Selth LA; Townley S; Gillis JL; Ochnik AM; Murti K; Macfarlane RJ; Chi KN; Marshall VR; Tilley WD; Butler LM
    Int J Cancer; 2012 Aug; 131(3):652-61. PubMed ID: 22052531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
    Buechner J; Henriksen JR; Haug BH; Tømte E; Flaegstad T; Einvik C
    Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.